Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Off-Label Compendia Weaknesses Illustrated By Tarceva Evidence Gaps

Oct 20 2016

• By Cathy Kelly

RollOfDollarswithPills_1200x675

Related Content

Tarceva Off-Label Marketing Caused 'Earlier' Death, DOJ Alleged

Jun 10 2016

Off-Label Debate Between FDA, Industry To Formally Begin After Election

Aug 31 2016

FDA's Pazdur Won't Become Oncology Bureaucrat: 'My Presence Will Be Felt'

Jun 30 2016

Related Companies

Roche Holding AG

Astellas Pharma, Inc.

Additional Topics

United States Market Access Reimbursement Cancer

More from Market Access

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window